cognitive cybersecurity intelligence
Clinical stage biotech company, Destiny Pharma, announced today (July 19) a positive update from the U.S. Food and Drug Administration (FDA) on its XF-73 nasal gel phase 3 development plans.
The FDA has clarified the phase 3 and U.S. registration pathway for the gel for the…
Source: www.labiotech.eu – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
International law enforcement has taken down AVCheck, a major platform that enabled cybercriminals to test if their malware could evade antivirus software detection. Investigators have
A critical security vulnerability in Azure Active Directory affects over 50,000 users, exposing sensitive data via an unsecured API endpoint in a JavaScript file. Discovered
As API dependency grows, so do security threats, with incidents more than doubling from 17% to 37% in 2024. Despite 95% of organizations facing API
Victoria’s Secret has temporarily removed its U.S. website following a security incident. The company is addressing the situation to ensure customer safety and data protection.
3000 Sand Hill Road, Building 3, Suite 210, Menlo Park, CA 94025
© 2024 HEAL Security, Inc. “Cognitive Cybersecurity Intelligence.” All rights reserved.
3000 Sand Hill Road, Building 3, Suite 210, Menlo Park, CA 94025.
California Consumer: Do Not Sell My Info
V2025.05.09